0001898714-26-000001.txt : 20260417 0001898714-26-000001.hdr.sgml : 20260417 20260417114517 ACCESSION NUMBER: 0001898714-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260417 DATE AS OF CHANGE: 20260417 EFFECTIVENESS DATE: 20260417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bonum Therapeutics, Inc. CENTRAL INDEX KEY: 0001898714 ORGANIZATION NAME: EIN: 872883314 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-580902 FILM NUMBER: 26870428 BUSINESS ADDRESS: STREET 1: 1150 EASTLAKE AVENUE E STREET 2: SUITE 1100 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-888-8485 MAIL ADDRESS: STREET 1: 1150 EASTLAKE AVENUE E STREET 2: SUITE 1100 CITY: SEATTLE STATE: WA ZIP: 98109 D 1 primary_doc.xml X0708 D LIVE 0001898714 Bonum Therapeutics, Inc. 1150 EASTLAKE AVENUE E SUITE 1100 SEATTLE WA WASHINGTON 98109 206-888-8485 DELAWARE None None Corporation true 2021 John Mulligan c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Executive Officer Director Promoter John McKearn c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Director Monique Schiersing c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Director Nicholas Walrod c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Director Karl Handelsman c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Director Diane Hollenbaugh c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Executive Officer Neela Patel c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Executive Officer Mitchell Mutz c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Director Samuel Bjork c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Director Gaurav Aggarwal c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Director Samuel Blackman c/o Bonum Therapeutics, Inc. 1150 Eastlake Ave. E., Suite 1100 Seattle WA WASHINGTON 98109 Director Biotechnology Decline to Disclose 06b false 2026-04-03 false true false 0 32301381 26907396 5393985 false 8 0 0 0 false Bonum Therapeutics, Inc. /s/ John Mulligan John Mulligan Chief Executive Officer 2026-04-17